Singapore markets closed

Rallybio Corporation (RLYB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6500+0.0600 (+3.77%)
As of 12:16PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
55,278
53,544
40,689
26,909
17,630
Selling general and administrative
25,067
25,388
27,195
18,739
7,673
Total operating expenses
80,345
78,932
67,884
45,648
25,303
Operating income or loss
-80,345
-78,932
-67,884
-45,648
-25,303
Interest expense
-
-
0
10
49
Total other income/expenses net
-1,807
-1,779
-733
96
241
Income before tax
-76,275
-74,564
-66,654
-45,508
-24,940
Income tax expense
-
-
-
0
-15
Income from continuing operations
-76,275
-74,564
-66,654
-47,013
-26,447
Net income
-76,275
-74,564
-66,654
-47,013
-26,447
Net income available to common shareholders
-76,275
-74,564
-66,654
-47,013
-26,447
Basic EPS
-1.79
-1.84
-2.09
-1.84
-1.19
Diluted EPS
-1.79
-1.84
-2.09
-1.84
-1.19
Basic average shares
39,186
40,447
31,821
25,519
22,245
Diluted average shares
39,186
40,447
31,821
25,519
22,245